Compare RAYMED LABS. with Sun Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

RAYMED LABS vs SUN PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    RAYMED LABS SUN PHARMA RAYMED LABS/
SUN PHARMA
 
P/E (TTM) x -5.4 28.6 - View Chart
P/BV x - 3.8 - View Chart
Dividend Yield % 0.0 1.0 -  

Financials

 RAYMED LABS   SUN PHARMA
EQUITY SHARE DATA
    RAYMED LABS
Mar-20
SUN PHARMA
Mar-21
RAYMED LABS/
SUN PHARMA
5-Yr Chart
Click to enlarge
High Rs3654 0.4%   
Low Rs1339 0.3%   
Sales per share (Unadj.) Rs0139.6 0.0%  
Earnings per share (Unadj.) Rs-0.19.5 -1.4%  
Cash flow per share (Unadj.) Rs-0.118.2 -0.6%  
Dividends per share (Unadj.) Rs07.50 0.0%  
Avg Dividend yield %01.5 0.0%  
Book value per share (Unadj.) Rs-4.6193.6 -2.4%  
Shares outstanding (eoy) m4.272,399.34 0.2%   
Bonus / Rights / Conversions ---  
Price / Sales ratio xNM3.6-  
Avg P/E ratio x-14.852.1 -28.4%  
P/CF ratio (eoy) x-16.627.3 -60.8%  
Price / Book Value ratio x-0.42.6 -16.2%  
Dividend payout %078.8 0.0%   
Avg Mkt Cap Rs m81,190,430 0.0%   
No. of employees `000NANA-   
Total wages/salary Rs m068,622 0.0%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m0334,981 0.0%  
Other income Rs m08,592 0.0%   
Total revenues Rs m0343,573 0.0%   
Gross profit Rs m-141,616 -0.0%  
Depreciation Rs m020,800 0.0%   
Interest Rs m01,414 0.0%   
Profit before tax Rs m-127,994 -0.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m05,147 0.0%   
Profit after tax Rs m-122,847 -0.0%  
Gross profit margin %NM12.4- 
Effective tax rate %018.4 0.0%   
Net profit margin %NM6.8- 
BALANCE SHEET DATA
Current assets Rs m1304,421 0.0%   
Current liabilities Rs m22161,456 0.0%   
Net working cap to sales %NM42.7- 
Current ratio x01.9 2.1%  
Inventory Days DaysNM149- 
Debtors Days DaysNM99- 
Net fixed assets Rs m2336,682 0.0%   
Share capital Rs m432,399 1.8%   
"Free" reserves Rs m-63462,229 -0.0%   
Net worth Rs m-20464,628 -0.0%   
Long term debt Rs m08,981 0.0%   
Total assets Rs m3641,103 0.0%  
Interest coverage xNM20.8-  
Debt to equity ratio x00 0.0%  
Sales to assets ratio x00.5 0.0%   
Return on assets %-21.73.8 -572.4%  
Return on equity %2.84.9 57.1%  
Return on capital %2.86.2 45.2%  
Exports to sales %NM0-  
Imports to sales %NM0-  
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m084,493 0.0%   
Fx outflow Rs m030,334 0.0%   
Net fx Rs m054,159 0.0%   
CASH FLOW
From Operations Rs m061,704 0.0%  
From Investments Rs mNA5,362 0.0%  
From Financial Activity Rs mNA-59,805 0.0%  
Net Cashflow Rs m05,964 0.0%  

Share Holding

Indian Promoters % 28.4 54.5 52.1%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 1.0 33.8 2.8%  
FIIs % 0.0 12.1 -  
ADR/GDR % 0.0 0.0 -  
Free float % 71.6 45.5 157.4%  
Shareholders   1,428 675,908 0.2%  
Pledged promoter(s) holding % 0.0 6.5 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare RAYMED LABS With:   BHARAT PARENTALS  ANG LIFESCIENCES INDIA  SUVEN LIFE SCIENCES  DECCAN HEALTH CARE  AMRUTANJAN HEALTHCARE  



Today's Market

Sensex Soars 620 Points, Nifty Ends Above 17,150; IndusInd Bank & JSW Steel Rally 5%(Closing)

Indian share markets witnessed positive trading activity throughout the day today and ended on a strong note.

Related Views on News

SUN PHARMA 2020-21 Annual Report Analysis (Annual Result Update)

Oct 22, 2021 | Updated on Oct 22, 2021

Here's an analysis of the annual report of SUN PHARMA for 2020-21. It includes a full income statement, balance sheet and cash flow analysis of SUN PHARMA. Also includes updates on the valuation of SUN PHARMA.

SUN PHARMA Announces Quarterly Results (3QFY21); Net Profit Up 87.4% (Quarterly Result Update)

Feb 1, 2021 | Updated on Feb 1, 2021

For the quarter ended December 2020, SUN PHARMA has posted a net profit of Rs 19 bn (up 87.4% YoY). Sales on the other hand came in at Rs 88 bn (up 8.4% YoY). Read on for a complete analysis of SUN PHARMA's quarterly results.

Sun Pharma Zooms 10% as June Quarter Earnings Beat Estimates (Views On News)

Jul 30, 2021

Here's a rundown on Sun Pharma's June quarter results.

Sun Pharma's Stock Falls 4% After Its March Quarter Results (Views On News)

May 28, 2021

In the past three months, the stock has outperformed the market by gaining nearly 20%. Can it go higher?

3 Indian Pharma Companies that are Investing Big Time for the Future (Views On News)

Nov 9, 2021

In 2021, R&D of pharma companies roared to life in a never-before-seen way.

More Views on News

Most Popular

Infosys vs TCS: Which is Better?(Views On News)

Nov 26, 2021

In the post pandemic era, the top two IT companies in India are fighting to capture the growing demand for IT.

This Multibagger Stock Zooms 20% After Dolly Khanna Buys Stake(Views On News)

Nov 24, 2021

Shares of this edible oil company zoomed over 50% in three days after ace investor bought around 1% stake.

6 Popular Stocks that Turned into Penny Stocks(Views On News)

Nov 27, 2021

A look at popular stocks that crashed big time and never recovered, i.e. which went from 'Multibaggers to Multibeggers'.

How to Find Your Next 10-Bagger in this Market(Profit Hunter)

Nov 19, 2021

The #1 make or break factor in your portfolio you shouldn't ignore.

MobiKwik IPO Opens for Subscription Soon. Key Things to Know Before Subscribing.(Views On News)

Nov 20, 2021

The Rs 19 bn issue is set to hit the market soon.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

RAYMED LABS SHARE PRICE


Nov 29, 2021 (Close)

TRACK RAYMED LABS

  • Track your investment in RAYMED LABS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

RAYMED LABS 5-YR ANALYSIS

COMPARE RAYMED LABS WITH

MARKET STATS